Zepbound® (Tirzepatide) Injection 15 mg/0.5 mL

Description

Zepbound® (Tirzepatide) Injection 15 mg/0.5 mL. Zepbound contains tirzepatide, a dual-action medication that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. These hormones work together to regulate appetite, slow digestion, and improve metabolic signaling. By targeting both pathways, Zepbound helps reduce hunger, increase feelings of fullness, and support sustained weight loss when combined with lifestyle changes.

The 15 mg dose is the highest maintenance dose of Zepbound and is typically prescribed only after patients have gradually titrated through lower doses. Each carton includes four single-use, pen-style prefilled syringes, with one injection administered weekly. The pen design allows for convenient at-home use under the supervision of a licensed healthcare provider.

Zepbound does not contain insulin, is not a combination drug, and is not approved to treat type 1 or type 2 diabetes, although improvements in metabolic markers may occur as weight is reduced.

---

How Zepbound Is Used

Zepbound is injected once per week, on the same day each week, just under the skin of the abdomen, thigh, or upper arm. Injection sites should be rotated weekly to reduce irritation.

Before injecting, inspect the pen to confirm the solution is clear and the medication has not expired. After cleaning the injection site with an alcohol swab, activate the pen according to the manufacturer’s instructions. Once the dose is delivered, the needle is automatically shielded.

Each pen is intended for single use only and must be disposed of in an approved sharps container. Pens should never be shared.

If a dose is missed, it may be taken as soon as remembered, provided the next scheduled dose is at least three days away. Patients should not take two doses in the same week unless directed by their healthcare provider.

---

Storage & Delivery Information

Zepbound pens must be stored in the refrigerator and should never be frozen. Because this medication requires refrigeration, an adult recipient must be available at delivery to ensure proper temperature control.

---

Important Medical Information

Zepbound is available by prescription only and should be used exactly as directed by a licensed healthcare provider. Weight loss results vary, and it may take several weeks to see noticeable changes. Patients should continue following a reduced-calorie diet and increased physical activity plan while using Zepbound.

Your healthcare provider will determine whether Zepbound 15 mg is appropriate based on your medical history, prior dose tolerance, and weight-loss goals.

---

What Makes Zepbound Different?

Zepbound uses the same active ingredient as Mounjaro® (tirzepatide) but is specifically FDA-approved for weight management. By targeting both GLP-1 and GIP receptors, Zepbound provides more robust appetite control and metabolic support than GLP-1–only medications, making it one of the most advanced prescription weight-loss injections available in the United States.